← Back
Data updated: Mar 10, 2026
MLV
Pharmaceuticals
MLV is a generic drug manufacturer with 3 FDA-approved products.
2009
Since
3
Drugs
-
Trials
21
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
ROPINIROLE HYDROCHLORIDE 2025-11-19
Labeling
ROPINIROLE HYDROCHLORIDE 2025-11-10
ROPINIROLE HYDROCHLORIDE 2025-09-30
Labeling
PYRIDOSTIGMINE BROMIDE 2025-09-26
Labeling
ROPINIROLE HYDROCHLORIDE 2025-09-16
Labeling
ROPINIROLE HYDROCHLORIDE 2025-09-16
Labeling
ROPINIROLE HYDROCHLORIDE 2025-09-16
Labeling
CARVEDILOL 2025-07-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 2009-12-22
- Latest
- 2024-10-09
- Applications
- 3